data_1ehj_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 1ehj _Structure_validation_residue.Date_analyzed 2016-10-06 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . 2.427 . . . . . . . 0 N--CA 1.474 0.744 0 N-CA-C 105.099 -2.185 . . . . 10.0 105.099 . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 27.6 p-10 -95.04 -37.03 11.3 Favored 'General case' 0 N--CA 1.442 -0.842 0 C-N-CA 128.626 2.77 . . . . 10.0 110.55 175.8 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 12.2 p -120.23 138.0 52.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 N-CA-C 108.691 -0.855 . . . . 10.0 108.691 164.108 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 94.2 t -126.33 163.34 28.51 Favored 'Isoleucine or valine' 0 C--O 1.234 0.286 0 N-CA-C 107.067 -1.456 . . . . 10.0 107.067 170.524 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 9.0 t -136.02 142.29 44.44 Favored 'General case' 0 N--CA 1.438 -1.038 0 N-CA-C 112.31 0.485 . . . . 10.0 112.31 158.603 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 97.3 m-85 -78.8 102.16 8.0 Favored 'General case' 0 C--O 1.238 0.486 0 N-CA-C 108.35 -0.981 . . . . 10.0 108.35 158.815 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -73.97 75.5 1.69 Allowed 'General case' 0 CA--C 1.531 0.249 0 CA-C-O 123.231 1.491 . . . . 10.0 110.753 171.931 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 8.8 p30 -89.57 168.32 12.25 Favored 'General case' 0 C--N 1.324 -0.512 0 C-N-CA 126.672 1.989 . . . . 10.0 109.599 178.975 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 2.3 tpmt? -66.48 -46.58 75.85 Favored 'General case' 0 N--CA 1.451 -0.405 0 C-N-CA 122.896 0.478 . . . . 10.0 112.241 -168.644 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 5.2 mmpt? -49.24 -55.66 11.87 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-O 121.481 0.658 . . . . 10.0 110.727 -176.447 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 165.42 122.17 0.59 Allowed Glycine 0 N--CA 1.44 -1.034 0 N-CA-C 104.621 -3.392 . . . . 10.0 104.621 -156.367 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 6.3 m120 -60.05 135.85 57.84 Favored 'General case' 0 N--CA 1.451 -0.396 0 N-CA-C 108.935 -0.765 . . . . 10.0 108.935 -167.172 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 37.0 t -96.93 102.32 13.33 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.373 0 N-CA-C 107.845 -1.168 . . . . 10.0 107.845 -177.68 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 26.9 m -69.88 143.11 52.89 Favored 'General case' 0 N--CA 1.45 -0.449 0 O-C-N 123.819 0.699 . . . . 10.0 109.114 172.33 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 20.6 p90 -143.91 114.48 7.6 Favored 'General case' 0 N--CA 1.45 -0.432 0 CA-C-O 122.156 0.979 . . . . 10.0 109.726 165.457 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -68.45 75.76 0.26 Allowed 'General case' 0 N--CA 1.446 -0.664 0 C-N-CA 126.297 1.839 . . . . 10.0 108.184 171.777 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 32.4 t-80 -41.99 -62.02 1.01 Allowed 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 127.21 2.204 . . . . 10.0 111.128 175.234 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 44.6 tttm -49.33 -53.48 21.93 Favored 'General case' 0 N--CA 1.452 -0.35 0 C-N-CA 126.318 1.847 . . . . 10.0 110.94 175.191 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -54.81 -55.88 25.44 Favored 'General case' 0 N--CA 1.454 -0.236 0 N-CA-C 110.26 -0.274 . . . . 10.0 110.26 -177.687 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 67.1 m80 -53.48 -41.33 66.12 Favored 'General case' 0 N--CA 1.451 -0.41 0 N-CA-C 108.725 -0.843 . . . . 10.0 108.725 177.992 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -60.71 -54.68 42.31 Favored 'General case' 0 C--O 1.22 -0.496 0 CA-C-N 116.474 -0.33 . . . . 10.0 111.359 -178.337 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -73.1 -39.92 65.4 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 121.09 -1.006 . . . . 10.0 110.893 -173.169 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 8.2 mmmt -58.73 -51.17 71.11 Favored 'General case' 0 N--CA 1.453 -0.321 0 C-N-CA 124.216 1.006 . . . . 10.0 111.078 173.278 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 22.3 mt -94.74 -57.02 2.58 Favored 'General case' 0 CA--C 1.529 0.171 0 C-N-CA 122.863 0.465 . . . . 10.0 111.013 -169.875 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 152.48 -84.02 0.16 Allowed Glycine 0 C--N 1.336 0.57 0 N-CA-C 108.15 -1.98 . . . . 10.0 108.15 -179.213 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 1.9 t 176.85 -51.53 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 124.479 1.111 . . . . 10.0 108.74 -176.725 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 22.8 p-10 -30.69 -47.86 0.1 Allowed 'General case' 0 N--CA 1.451 -0.4 0 C-N-CA 130.208 3.403 . . . . 10.0 111.464 166.876 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -37.55 -42.37 0.53 Allowed 'General case' 0 N--CA 1.448 -0.543 0 C-N-CA 126.785 2.034 . . . . 10.0 112.991 177.146 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 42.7 m -124.58 -34.39 2.87 Favored 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 123.52 0.728 . . . . 10.0 112.104 -176.116 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 97.3 m-70 -118.24 92.3 3.79 Favored 'General case' 0 N--CA 1.454 -0.264 0 C-N-CA 124.121 0.968 . . . . 10.0 109.388 -173.912 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 17.0 mt-10 -72.39 -64.95 0.85 Allowed 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 122.419 1.104 . . . . 10.0 110.024 -176.942 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -75.4 -64.42 2.28 Favored Glycine 0 CA--C 1.524 0.652 0 CA-C-N 113.774 -1.557 . . . . 10.0 110.931 -170.971 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 5.7 t -163.47 146.97 8.31 Favored Pre-proline 0 N--CA 1.453 -0.28 0 N-CA-C 106.281 -1.748 . . . . 10.0 106.281 176.088 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -75.6 137.9 20.99 Favored 'Trans proline' 0 N--CA 1.449 -1.139 0 C-N-CA 122.064 1.843 . . . . 10.0 110.162 174.317 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -155.81 58.11 0.61 Allowed 'General case' 0 N--CA 1.454 -0.248 0 N-CA-C 106.414 -1.698 . . . . 10.0 106.414 176.8 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . 0.411 ' NZ ' ' O1D' ' A' 1030 ' ' HEC . 1.8 mtmt 59.11 -171.98 0.11 Allowed 'General case' 0 CA--C 1.534 0.341 0 CA-C-N 114.816 -1.083 . . . . 10.0 110.429 -154.446 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 6.8 mt -134.76 -50.1 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.43 0 C-N-CA 123.806 0.842 . . . . 10.0 109.269 159.134 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . 73.16 70.78 0.13 Allowed 'General case' 0 N--CA 1.454 -0.253 0 C-N-CA 127.576 2.35 . . . . 10.0 109.421 -176.419 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 26.8 mm -83.45 105.97 13.6 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.489 0 N-CA-C 108.618 -0.882 . . . . 10.0 108.618 -179.431 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 2.3 p-10 -95.01 178.44 5.56 Favored 'General case' 0 CA--C 1.517 -0.309 0 C-N-CA 125.179 1.391 . . . . 10.0 109.647 -178.692 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -39.95 -59.58 1.18 Allowed 'General case' 0 C--N 1.33 -0.272 0 C-N-CA 125.486 1.514 . . . . 10.0 110.469 173.193 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 46.2 mtpt -55.54 -64.86 0.71 Allowed 'General case' 0 N--CA 1.449 -0.486 0 N-CA-C 108.653 -0.869 . . . . 10.0 108.653 -176.491 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 14.6 m -54.1 -56.59 16.59 Favored 'General case' 0 N--CA 1.453 -0.279 0 CA-C-O 120.717 0.294 . . . . 10.0 110.394 -174.075 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -44.56 -59.65 2.36 Favored 'General case' 0 N--CA 1.452 -0.333 0 C-N-CA 127.743 2.417 . . . . 10.0 111.456 178.719 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 8.3 m170 -73.36 -28.81 62.24 Favored 'General case' 0 N--CA 1.446 -0.629 0 CA-C-O 118.799 -0.619 . . . . 10.0 111.609 -175.779 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 12.8 tmtt? -84.18 -72.63 0.46 Allowed 'General case' 0 N--CA 1.454 -0.249 0 N-CA-C 108.265 -1.013 . . . . 10.0 108.265 -169.373 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 12.9 m-20 -147.71 71.84 1.21 Allowed 'General case' 0 N--CA 1.455 -0.212 0 N-CA-C 108.523 -0.917 . . . . 10.0 108.523 -179.824 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -147.46 -86.69 0.09 Allowed 'General case' 0 N--CA 1.448 -0.555 0 N-CA-C 108.234 -1.024 . . . . 10.0 108.234 161.075 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 4.4 m -69.77 -61.02 1.95 Allowed 'General case' 0 CA--C 1.532 0.281 0 CA-C-O 122.295 1.045 . . . . 10.0 109.134 -178.145 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 1.6 ttpm? -82.63 39.23 0.6 Allowed 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 123.961 0.904 . . . . 10.0 111.478 -168.584 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -134.5 -52.59 0.82 Allowed 'General case' 0 N--CA 1.455 -0.188 0 N-CA-C 107.105 -1.443 . . . . 10.0 107.105 171.911 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -50.13 -52.22 36.92 Favored 'General case' 0 N--CA 1.454 -0.227 0 C-N-CA 124.043 0.937 . . . . 10.0 111.351 175.302 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 63.9 m170 -61.61 -27.24 68.51 Favored 'General case' 0 N--CA 1.45 -0.454 0 CA-C-O 117.977 -1.011 . . . . 10.0 112.311 -169.001 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 48.3 mtpt -42.7 -51.36 5.32 Favored 'General case' 0 N--CA 1.466 0.33 0 C-N-CA 124.662 1.185 . . . . 10.0 112.338 -174.078 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 8.5 m -85.37 -7.0 59.18 Favored 'General case' 0 CA--C 1.533 0.324 0 N-CA-C 112.899 0.703 . . . . 10.0 112.899 -175.48 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 61.5 m-80 -102.23 -49.68 3.84 Favored 'General case' 0 CA--C 1.528 0.113 0 C-N-CA 124.557 1.143 . . . . 10.0 110.725 -172.347 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 48.9 t30 -148.79 165.6 30.97 Favored 'General case' 0 CA--C 1.53 0.184 0 N-CA-C 107.247 -1.39 . . . . 10.0 107.247 177.84 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -113.4 69.45 0.23 Allowed Glycine 0 CA--C 1.53 1.021 0 CA-C-O 118.75 -1.028 . . . . 10.0 113.09 -175.054 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 84.3 Cg_endo -68.31 111.94 2.65 Favored 'Trans proline' 0 N--CA 1.452 -0.94 0 N-CA-C 106.044 -2.329 . . . . 10.0 106.044 160.332 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 6.3 p -84.33 -59.53 2.36 Favored 'General case' 0 N--CA 1.452 -0.365 0 N-CA-C 108.478 -0.934 . . . . 10.0 108.478 -164.786 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 86.0 mttt -92.89 -93.86 0.15 Allowed 'General case' 0 N--CA 1.445 -0.704 0 CA-C-N 114.249 -1.341 . . . . 10.0 107.987 178.271 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 4.0 m -132.66 -155.23 0.67 Allowed 'General case' 0 CA--C 1.53 0.192 0 C-N-CA 125.46 1.504 . . . . 10.0 109.737 -173.351 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 83.34 -40.01 2.82 Favored Glycine 0 CA--C 1.526 0.777 0 N-CA-C 111.539 -0.624 . . . . 10.0 111.539 169.9 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -38.41 -44.15 1.64 Allowed Glycine 0 CA--C 1.53 1.001 0 C-N-CA 126.2 1.857 . . . . 10.0 113.677 177.296 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' CYS . . . . . . . . . . . . . 25.7 m -120.9 -56.03 1.96 Allowed 'General case' 0 CA--C 1.529 0.143 0 C-N-CA 124.078 0.951 . . . . 10.0 110.037 -171.563 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 96.3 m-70 -65.75 113.66 4.46 Favored 'General case' 0 C--N 1.34 0.175 0 N-CA-C 108.374 -0.973 . . . . 10.0 108.374 177.481 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 28.4 mm -76.35 74.05 0.48 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.438 0 N-CA-C 108.65 -0.871 . . . . 10.0 108.65 176.869 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--O 1.249 1.074 0 C-N-CA 126.35 1.86 . . . . 10.0 106.744 179.091 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1030 ' ' HEC . . . . . 0.411 ' O1D' ' NZ ' ' A' ' 36' ' ' LYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1053 ' ' HEC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A 1066 ' ' HEC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . 2.427 . . . . . . . 0 N--CA 1.474 0.744 0 N-CA-C 105.099 -2.185 . . . . 10.0 105.099 . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 27.6 p-10 -95.04 -37.03 11.3 Favored 'General case' 0 N--CA 1.442 -0.842 0 C-N-CA 128.626 2.77 . . . . 10.0 110.55 175.8 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 12.2 p -120.23 138.0 52.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 N-CA-C 108.691 -0.855 . . . . 10.0 108.691 164.108 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.4 HG12 ' N ' ' A' ' 5' ' ' THR . 94.2 t -126.33 163.34 28.51 Favored 'Isoleucine or valine' 0 C--O 1.234 0.286 0 N-CA-C 107.067 -1.456 . . . . 10.0 107.067 170.524 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 5' ' ' THR . . . . . 0.4 ' N ' HG12 ' A' ' 4' ' ' VAL . 9.0 t -136.02 142.29 44.44 Favored 'General case' 0 N--CA 1.438 -1.038 0 N-CA-C 112.31 0.485 . . . . 10.0 112.31 158.603 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 97.3 m-85 -78.8 102.16 8.0 Favored 'General case' 0 C--O 1.238 0.486 0 N-CA-C 108.35 -0.981 . . . . 10.0 108.35 158.815 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -73.97 75.5 1.69 Allowed 'General case' 0 CA--C 1.531 0.249 0 CA-C-O 123.231 1.491 . . . . 10.0 110.753 171.931 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 8.8 p30 -89.57 168.32 12.25 Favored 'General case' 0 C--N 1.324 -0.512 0 C-N-CA 126.672 1.989 . . . . 10.0 109.599 178.975 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 2.3 tpmt? -66.48 -46.58 75.85 Favored 'General case' 0 N--CA 1.451 -0.405 0 C-N-CA 122.896 0.478 . . . . 10.0 112.241 -168.644 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 5.2 mmpt? -49.24 -55.66 11.87 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-O 121.481 0.658 . . . . 10.0 110.727 -176.447 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 165.42 122.17 0.59 Allowed Glycine 0 N--CA 1.44 -1.034 0 N-CA-C 104.621 -3.392 . . . . 10.0 104.621 -156.367 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 40.2 m-20 -60.05 135.85 57.84 Favored 'General case' 0 N--CA 1.451 -0.396 0 N-CA-C 108.935 -0.765 . . . . 10.0 108.935 -167.172 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.81 HG11 HMD3 ' A' 1066 ' ' HEC . 37.0 t -96.93 102.32 13.33 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.373 0 N-CA-C 107.845 -1.168 . . . . 10.0 107.845 -177.68 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 26.9 m -69.88 143.11 52.89 Favored 'General case' 0 N--CA 1.45 -0.449 0 O-C-N 123.819 0.699 . . . . 10.0 109.114 172.33 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 20.6 p90 -143.91 114.48 7.6 Favored 'General case' 0 N--CA 1.45 -0.432 0 CA-C-O 122.156 0.979 . . . . 10.0 109.726 165.457 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -68.45 75.76 0.26 Allowed 'General case' 0 N--CA 1.446 -0.664 0 C-N-CA 126.297 1.839 . . . . 10.0 108.184 171.777 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 32.4 t-80 -41.99 -62.02 1.01 Allowed 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 127.21 2.204 . . . . 10.0 111.128 175.234 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 44.6 tttm -49.33 -53.48 21.93 Favored 'General case' 0 N--CA 1.452 -0.35 0 C-N-CA 126.318 1.847 . . . . 10.0 110.94 175.191 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -54.81 -55.88 25.44 Favored 'General case' 0 N--CA 1.454 -0.236 0 N-CA-C 110.26 -0.274 . . . . 10.0 110.26 -177.687 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 67.1 m80 -53.48 -41.33 66.12 Favored 'General case' 0 N--CA 1.451 -0.41 0 N-CA-C 108.725 -0.843 . . . . 10.0 108.725 177.992 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -60.71 -54.68 42.31 Favored 'General case' 0 C--O 1.22 -0.496 0 CA-C-N 116.474 -0.33 . . . . 10.0 111.359 -178.337 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -73.1 -39.92 65.4 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 121.09 -1.006 . . . . 10.0 110.893 -173.169 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 8.2 mmmt -58.73 -51.17 71.11 Favored 'General case' 0 N--CA 1.453 -0.321 0 C-N-CA 124.216 1.006 . . . . 10.0 111.078 173.278 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 22.3 mt -94.74 -57.02 2.58 Favored 'General case' 0 CA--C 1.529 0.171 0 C-N-CA 122.863 0.465 . . . . 10.0 111.013 -169.875 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 152.48 -84.02 0.16 Allowed Glycine 0 C--N 1.336 0.57 0 N-CA-C 108.15 -1.98 . . . . 10.0 108.15 -179.213 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 1.9 t 176.85 -51.53 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 124.479 1.111 . . . . 10.0 108.74 -176.725 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 22.8 p-10 -30.69 -47.86 0.1 Allowed 'General case' 0 N--CA 1.451 -0.4 0 C-N-CA 130.208 3.403 . . . . 10.0 111.464 166.876 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -37.55 -42.37 0.53 Allowed 'General case' 0 N--CA 1.448 -0.543 0 C-N-CA 126.785 2.034 . . . . 10.0 112.991 177.146 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 42.7 m -124.58 -34.39 2.87 Favored 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 123.52 0.728 . . . . 10.0 112.104 -176.116 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 97.3 m-70 -118.24 92.3 3.79 Favored 'General case' 0 N--CA 1.454 -0.264 0 C-N-CA 124.121 0.968 . . . . 10.0 109.388 -173.912 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 17.0 mt-10 -72.39 -64.95 0.85 Allowed 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 122.419 1.104 . . . . 10.0 110.024 -176.942 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -75.4 -64.42 2.28 Favored Glycine 0 CA--C 1.524 0.652 0 CA-C-N 113.774 -1.557 . . . . 10.0 110.931 -170.971 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 5.7 t -163.47 146.97 8.31 Favored Pre-proline 0 N--CA 1.453 -0.28 0 N-CA-C 106.281 -1.748 . . . . 10.0 106.281 176.088 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -75.6 137.9 20.99 Favored 'Trans proline' 0 N--CA 1.449 -1.139 0 C-N-CA 122.064 1.843 . . . . 10.0 110.162 174.317 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -155.81 58.11 0.61 Allowed 'General case' 0 N--CA 1.454 -0.248 0 N-CA-C 106.414 -1.698 . . . . 10.0 106.414 176.8 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 36' ' ' LYS . . . . . 0.411 ' NZ ' ' O1D' ' A' 1030 ' ' HEC . 1.8 mtmt 59.11 -171.98 0.11 Allowed 'General case' 0 CA--C 1.534 0.341 0 CA-C-N 114.816 -1.083 . . . . 10.0 110.429 -154.446 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 6.8 mt -134.76 -50.1 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.43 0 C-N-CA 123.806 0.842 . . . . 10.0 109.269 159.134 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . 73.16 70.78 0.13 Allowed 'General case' 0 N--CA 1.454 -0.253 0 C-N-CA 127.576 2.35 . . . . 10.0 109.421 -176.419 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 26.8 mm -83.45 105.97 13.6 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.489 0 N-CA-C 108.618 -0.882 . . . . 10.0 108.618 -179.431 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 2.3 p-10 -95.01 178.44 5.56 Favored 'General case' 0 CA--C 1.517 -0.309 0 C-N-CA 125.179 1.391 . . . . 10.0 109.647 -178.692 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -39.95 -59.58 1.18 Allowed 'General case' 0 C--N 1.33 -0.272 0 C-N-CA 125.486 1.514 . . . . 10.0 110.469 173.193 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 46.2 mtpt -55.54 -64.86 0.71 Allowed 'General case' 0 N--CA 1.449 -0.486 0 N-CA-C 108.653 -0.869 . . . . 10.0 108.653 -176.491 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 14.6 m -54.1 -56.59 16.59 Favored 'General case' 0 N--CA 1.453 -0.279 0 CA-C-O 120.717 0.294 . . . . 10.0 110.394 -174.075 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -44.56 -59.65 2.36 Favored 'General case' 0 N--CA 1.452 -0.333 0 C-N-CA 127.743 2.417 . . . . 10.0 111.456 178.719 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 8.3 m170 -73.36 -28.81 62.24 Favored 'General case' 0 N--CA 1.446 -0.629 0 CA-C-O 118.799 -0.619 . . . . 10.0 111.609 -175.779 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 12.8 tmtt? -84.18 -72.63 0.46 Allowed 'General case' 0 N--CA 1.454 -0.249 0 N-CA-C 108.265 -1.013 . . . . 10.0 108.265 -169.373 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 12.9 m-20 -147.71 71.84 1.21 Allowed 'General case' 0 N--CA 1.455 -0.212 0 N-CA-C 108.523 -0.917 . . . . 10.0 108.523 -179.824 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -147.46 -86.69 0.09 Allowed 'General case' 0 N--CA 1.448 -0.555 0 N-CA-C 108.234 -1.024 . . . . 10.0 108.234 161.075 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 4.4 m -69.77 -61.02 1.95 Allowed 'General case' 0 CA--C 1.532 0.281 0 CA-C-O 122.295 1.045 . . . . 10.0 109.134 -178.145 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 1.6 ttpm? -82.63 39.23 0.6 Allowed 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 123.961 0.904 . . . . 10.0 111.478 -168.584 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -134.5 -52.59 0.82 Allowed 'General case' 0 N--CA 1.455 -0.188 0 N-CA-C 107.105 -1.443 . . . . 10.0 107.105 171.911 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -50.13 -52.22 36.92 Favored 'General case' 0 N--CA 1.454 -0.227 0 C-N-CA 124.043 0.937 . . . . 10.0 111.351 175.302 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 63.9 m170 -61.61 -27.24 68.51 Favored 'General case' 0 N--CA 1.45 -0.454 0 CA-C-O 117.977 -1.011 . . . . 10.0 112.311 -169.001 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 48.3 mtpt -42.7 -51.36 5.32 Favored 'General case' 0 N--CA 1.466 0.33 0 C-N-CA 124.662 1.185 . . . . 10.0 112.338 -174.078 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 8.5 m -85.37 -7.0 59.18 Favored 'General case' 0 CA--C 1.533 0.324 0 N-CA-C 112.899 0.703 . . . . 10.0 112.899 -175.48 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 61.5 m-80 -102.23 -49.68 3.84 Favored 'General case' 0 CA--C 1.528 0.113 0 C-N-CA 124.557 1.143 . . . . 10.0 110.725 -172.347 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 48.9 t30 -148.79 165.6 30.97 Favored 'General case' 0 CA--C 1.53 0.184 0 N-CA-C 107.247 -1.39 . . . . 10.0 107.247 177.84 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -113.4 69.45 0.23 Allowed Glycine 0 CA--C 1.53 1.021 0 CA-C-O 118.75 -1.028 . . . . 10.0 113.09 -175.054 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 84.3 Cg_endo -68.31 111.94 2.65 Favored 'Trans proline' 0 N--CA 1.452 -0.94 0 N-CA-C 106.044 -2.329 . . . . 10.0 106.044 160.332 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 6.3 p -84.33 -59.53 2.36 Favored 'General case' 0 N--CA 1.452 -0.365 0 N-CA-C 108.478 -0.934 . . . . 10.0 108.478 -164.786 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 86.0 mttt -92.89 -93.86 0.15 Allowed 'General case' 0 N--CA 1.445 -0.704 0 CA-C-N 114.249 -1.341 . . . . 10.0 107.987 178.271 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 4.0 m -132.66 -155.23 0.67 Allowed 'General case' 0 CA--C 1.53 0.192 0 C-N-CA 125.46 1.504 . . . . 10.0 109.737 -173.351 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 83.34 -40.01 2.82 Favored Glycine 0 CA--C 1.526 0.777 0 N-CA-C 111.539 -0.624 . . . . 10.0 111.539 169.9 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -38.41 -44.15 1.64 Allowed Glycine 0 CA--C 1.53 1.001 0 C-N-CA 126.2 1.857 . . . . 10.0 113.677 177.296 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 65' ' ' CYS . . . . . 0.446 ' HB3' HG13 ' A' ' 13' ' ' VAL . 25.7 m -120.9 -56.03 1.96 Allowed 'General case' 0 CA--C 1.529 0.143 0 C-N-CA 124.078 0.951 . . . . 10.0 110.037 -171.563 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 96.3 m-70 -65.75 113.66 4.46 Favored 'General case' 0 C--N 1.34 0.175 0 N-CA-C 108.374 -0.973 . . . . 10.0 108.374 177.481 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 28.4 mm -76.35 74.05 0.48 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.438 0 N-CA-C 108.65 -0.871 . . . . 10.0 108.65 176.869 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--O 1.249 1.074 0 C-N-CA 126.35 1.86 . . . . 10.0 106.744 179.091 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1030 ' ' HEC . . . . . 0.914 HMB1 HBB3 ' A' 1030 ' ' HEC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1053 ' ' HEC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A 1066 ' ' HEC . . . . . 0.81 HMD3 HG11 ' A' ' 13' ' ' VAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . 2.427 . . . . . . . 0 N--CA 1.474 0.744 0 N-CA-C 105.099 -2.185 . . . . 10.0 105.099 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 27.6 p-10 -95.04 -37.03 11.3 Favored 'General case' 0 N--CA 1.442 -0.842 0 C-N-CA 128.626 2.77 . . . . 10.0 110.55 175.8 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 12.2 p -120.23 138.0 52.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 N-CA-C 108.691 -0.855 . . . . 10.0 108.691 164.108 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.4 HG12 ' N ' ' A' ' 5' ' ' THR . 94.2 t -126.33 163.34 28.51 Favored 'Isoleucine or valine' 0 C--O 1.234 0.286 0 N-CA-C 107.067 -1.456 . . . . 10.0 107.067 170.524 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . 0.4 ' N ' HG12 ' A' ' 4' ' ' VAL . 9.0 t -136.02 142.29 44.44 Favored 'General case' 0 N--CA 1.438 -1.038 0 N-CA-C 112.31 0.485 . . . . 10.0 112.31 158.603 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 97.3 m-85 -78.8 102.16 8.0 Favored 'General case' 0 C--O 1.238 0.486 0 N-CA-C 108.35 -0.981 . . . . 10.0 108.35 158.815 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -73.97 75.5 1.69 Allowed 'General case' 0 CA--C 1.531 0.249 0 CA-C-O 123.231 1.491 . . . . 10.0 110.753 171.931 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 8.8 p30 -89.57 168.32 12.25 Favored 'General case' 0 C--N 1.324 -0.512 0 C-N-CA 126.672 1.989 . . . . 10.0 109.599 178.975 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 2.3 tpmt? -66.48 -46.58 75.85 Favored 'General case' 0 N--CA 1.451 -0.405 0 C-N-CA 122.896 0.478 . . . . 10.0 112.241 -168.644 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 5.2 mmpt? -49.24 -55.66 11.87 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-O 121.481 0.658 . . . . 10.0 110.727 -176.447 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 165.42 122.17 0.59 Allowed Glycine 0 N--CA 1.44 -1.034 0 N-CA-C 104.621 -3.392 . . . . 10.0 104.621 -156.367 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 6.3 m120 -60.05 135.85 57.84 Favored 'General case' 0 N--CA 1.451 -0.396 0 N-CA-C 108.935 -0.765 . . . . 10.0 108.935 -167.172 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.81 HG11 HMD3 ' A' 1066 ' ' HEC . 37.0 t -96.93 102.32 13.33 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.373 0 N-CA-C 107.845 -1.168 . . . . 10.0 107.845 -177.68 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 26.9 m -69.88 143.11 52.89 Favored 'General case' 0 N--CA 1.45 -0.449 0 O-C-N 123.819 0.699 . . . . 10.0 109.114 172.33 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 20.6 p90 -143.91 114.48 7.6 Favored 'General case' 0 N--CA 1.45 -0.432 0 CA-C-O 122.156 0.979 . . . . 10.0 109.726 165.457 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -68.45 75.76 0.26 Allowed 'General case' 0 N--CA 1.446 -0.664 0 C-N-CA 126.297 1.839 . . . . 10.0 108.184 171.777 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 32.4 t-80 -41.99 -62.02 1.01 Allowed 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 127.21 2.204 . . . . 10.0 111.128 175.234 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 44.6 tttm -49.33 -53.48 21.93 Favored 'General case' 0 N--CA 1.452 -0.35 0 C-N-CA 126.318 1.847 . . . . 10.0 110.94 175.191 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -54.81 -55.88 25.44 Favored 'General case' 0 N--CA 1.454 -0.236 0 N-CA-C 110.26 -0.274 . . . . 10.0 110.26 -177.687 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 67.1 m80 -53.48 -41.33 66.12 Favored 'General case' 0 N--CA 1.451 -0.41 0 N-CA-C 108.725 -0.843 . . . . 10.0 108.725 177.992 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -60.71 -54.68 42.31 Favored 'General case' 0 C--O 1.22 -0.496 0 CA-C-N 116.474 -0.33 . . . . 10.0 111.359 -178.337 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -73.1 -39.92 65.4 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 121.09 -1.006 . . . . 10.0 110.893 -173.169 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 8.2 mmmt -58.73 -51.17 71.11 Favored 'General case' 0 N--CA 1.453 -0.321 0 C-N-CA 124.216 1.006 . . . . 10.0 111.078 173.278 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 22.3 mt -94.74 -57.02 2.58 Favored 'General case' 0 CA--C 1.529 0.171 0 C-N-CA 122.863 0.465 . . . . 10.0 111.013 -169.875 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 152.48 -84.02 0.16 Allowed Glycine 0 C--N 1.336 0.57 0 N-CA-C 108.15 -1.98 . . . . 10.0 108.15 -179.213 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 1.9 t 176.85 -51.53 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 124.479 1.111 . . . . 10.0 108.74 -176.725 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 22.8 p-10 -30.69 -47.86 0.1 Allowed 'General case' 0 N--CA 1.451 -0.4 0 C-N-CA 130.208 3.403 . . . . 10.0 111.464 166.876 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -37.55 -42.37 0.53 Allowed 'General case' 0 N--CA 1.448 -0.543 0 C-N-CA 126.785 2.034 . . . . 10.0 112.991 177.146 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 42.7 m -124.58 -34.39 2.87 Favored 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 123.52 0.728 . . . . 10.0 112.104 -176.116 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 97.3 m-70 -118.24 92.3 3.79 Favored 'General case' 0 N--CA 1.454 -0.264 0 C-N-CA 124.121 0.968 . . . . 10.0 109.388 -173.912 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 17.0 mt-10 -72.39 -64.95 0.85 Allowed 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 122.419 1.104 . . . . 10.0 110.024 -176.942 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -75.4 -64.42 2.28 Favored Glycine 0 CA--C 1.524 0.652 0 CA-C-N 113.774 -1.557 . . . . 10.0 110.931 -170.971 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 5.7 t -163.47 146.97 8.31 Favored Pre-proline 0 N--CA 1.453 -0.28 0 N-CA-C 106.281 -1.748 . . . . 10.0 106.281 176.088 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -75.6 137.9 20.99 Favored 'Trans proline' 0 N--CA 1.449 -1.139 0 C-N-CA 122.064 1.843 . . . . 10.0 110.162 174.317 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -155.81 58.11 0.61 Allowed 'General case' 0 N--CA 1.454 -0.248 0 N-CA-C 106.414 -1.698 . . . . 10.0 106.414 176.8 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . 0.411 ' NZ ' ' O1D' ' A' 1030 ' ' HEC . 1.8 mtmt 59.11 -171.98 0.11 Allowed 'General case' 0 CA--C 1.534 0.341 0 CA-C-N 114.816 -1.083 . . . . 10.0 110.429 -154.446 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 6.8 mt -134.76 -50.1 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.43 0 C-N-CA 123.806 0.842 . . . . 10.0 109.269 159.134 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . 73.16 70.78 0.13 Allowed 'General case' 0 N--CA 1.454 -0.253 0 C-N-CA 127.576 2.35 . . . . 10.0 109.421 -176.419 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 26.8 mm -83.45 105.97 13.6 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.489 0 N-CA-C 108.618 -0.882 . . . . 10.0 108.618 -179.431 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 2.3 p-10 -95.01 178.44 5.56 Favored 'General case' 0 CA--C 1.517 -0.309 0 C-N-CA 125.179 1.391 . . . . 10.0 109.647 -178.692 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -39.95 -59.58 1.18 Allowed 'General case' 0 C--N 1.33 -0.272 0 C-N-CA 125.486 1.514 . . . . 10.0 110.469 173.193 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 46.2 mtpt -55.54 -64.86 0.71 Allowed 'General case' 0 N--CA 1.449 -0.486 0 N-CA-C 108.653 -0.869 . . . . 10.0 108.653 -176.491 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 14.6 m -54.1 -56.59 16.59 Favored 'General case' 0 N--CA 1.453 -0.279 0 CA-C-O 120.717 0.294 . . . . 10.0 110.394 -174.075 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -44.56 -59.65 2.36 Favored 'General case' 0 N--CA 1.452 -0.333 0 C-N-CA 127.743 2.417 . . . . 10.0 111.456 178.719 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 8.3 m170 -73.36 -28.81 62.24 Favored 'General case' 0 N--CA 1.446 -0.629 0 CA-C-O 118.799 -0.619 . . . . 10.0 111.609 -175.779 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 12.8 tmtt? -84.18 -72.63 0.46 Allowed 'General case' 0 N--CA 1.454 -0.249 0 N-CA-C 108.265 -1.013 . . . . 10.0 108.265 -169.373 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 12.9 m-20 -147.71 71.84 1.21 Allowed 'General case' 0 N--CA 1.455 -0.212 0 N-CA-C 108.523 -0.917 . . . . 10.0 108.523 -179.824 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -147.46 -86.69 0.09 Allowed 'General case' 0 N--CA 1.448 -0.555 0 N-CA-C 108.234 -1.024 . . . . 10.0 108.234 161.075 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 4.4 m -69.77 -61.02 1.95 Allowed 'General case' 0 CA--C 1.532 0.281 0 CA-C-O 122.295 1.045 . . . . 10.0 109.134 -178.145 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 1.6 ttpm? -82.63 39.23 0.6 Allowed 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 123.961 0.904 . . . . 10.0 111.478 -168.584 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -134.5 -52.59 0.82 Allowed 'General case' 0 N--CA 1.455 -0.188 0 N-CA-C 107.105 -1.443 . . . . 10.0 107.105 171.911 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -50.13 -52.22 36.92 Favored 'General case' 0 N--CA 1.454 -0.227 0 C-N-CA 124.043 0.937 . . . . 10.0 111.351 175.302 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 63.9 m170 -61.61 -27.24 68.51 Favored 'General case' 0 N--CA 1.45 -0.454 0 CA-C-O 117.977 -1.011 . . . . 10.0 112.311 -169.001 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 48.3 mtpt -42.7 -51.36 5.32 Favored 'General case' 0 N--CA 1.466 0.33 0 C-N-CA 124.662 1.185 . . . . 10.0 112.338 -174.078 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 8.5 m -85.37 -7.0 59.18 Favored 'General case' 0 CA--C 1.533 0.324 0 N-CA-C 112.899 0.703 . . . . 10.0 112.899 -175.48 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 61.5 m-80 -102.23 -49.68 3.84 Favored 'General case' 0 CA--C 1.528 0.113 0 C-N-CA 124.557 1.143 . . . . 10.0 110.725 -172.347 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 48.9 t30 -148.79 165.6 30.97 Favored 'General case' 0 CA--C 1.53 0.184 0 N-CA-C 107.247 -1.39 . . . . 10.0 107.247 177.84 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -113.4 69.45 0.23 Allowed Glycine 0 CA--C 1.53 1.021 0 CA-C-O 118.75 -1.028 . . . . 10.0 113.09 -175.054 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 84.3 Cg_endo -68.31 111.94 2.65 Favored 'Trans proline' 0 N--CA 1.452 -0.94 0 N-CA-C 106.044 -2.329 . . . . 10.0 106.044 160.332 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 6.3 p -84.33 -59.53 2.36 Favored 'General case' 0 N--CA 1.452 -0.365 0 N-CA-C 108.478 -0.934 . . . . 10.0 108.478 -164.786 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 86.0 mttt -92.89 -93.86 0.15 Allowed 'General case' 0 N--CA 1.445 -0.704 0 CA-C-N 114.249 -1.341 . . . . 10.0 107.987 178.271 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 4.0 m -132.66 -155.23 0.67 Allowed 'General case' 0 CA--C 1.53 0.192 0 C-N-CA 125.46 1.504 . . . . 10.0 109.737 -173.351 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 83.34 -40.01 2.82 Favored Glycine 0 CA--C 1.526 0.777 0 N-CA-C 111.539 -0.624 . . . . 10.0 111.539 169.9 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -38.41 -44.15 1.64 Allowed Glycine 0 CA--C 1.53 1.001 0 C-N-CA 126.2 1.857 . . . . 10.0 113.677 177.296 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' CYS . . . . . 0.446 ' HB3' HG13 ' A' ' 13' ' ' VAL . 25.7 m -120.9 -56.03 1.96 Allowed 'General case' 0 CA--C 1.529 0.143 0 C-N-CA 124.078 0.951 . . . . 10.0 110.037 -171.563 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 96.3 m-70 -65.75 113.66 4.46 Favored 'General case' 0 C--N 1.34 0.175 0 N-CA-C 108.374 -0.973 . . . . 10.0 108.374 177.481 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 28.4 mm -76.35 74.05 0.48 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.438 0 N-CA-C 108.65 -0.871 . . . . 10.0 108.65 176.869 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--O 1.249 1.074 0 C-N-CA 126.35 1.86 . . . . 10.0 106.744 179.091 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1030 ' ' HEC . . . . . 0.914 HMB1 HBB3 ' A' 1030 ' ' HEC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1053 ' ' HEC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A 1066 ' ' HEC . . . . . 0.81 HMD3 HG11 ' A' ' 13' ' ' VAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 stop_ save_